Subgroup analyses based on cancer types revealed significant reverse associations between L1CAM expression and DFS in neuroblastoma, ovarian cancer, neuroendocrine tumours, gallbladder cancer, hepatocellular cancer and endometrial cancer (Table 2). This evidence concerns the gene L1CAM and cancer.